Dr. William W. Harless, MD, PhD

Dr. Harless practices at Parkview Bryan Hospital in Bryan, Ohio, part of Parkview Health System.

Dr. Harless' NPI, 1528100948, was assigned on February 13, 2007. Dr. Harless holds West Virginia license 21423.

Dr. Harless' primary practice is Parkview Bryan Hospital, at 433 West High Street, Bryan, OH 43506 in Williams County. The practice phone is (419) 636-1131.

Dr. Harless' primary practice is Parkview Bryan Hospital in Bryan, Ohio, part of Parkview Health System. Dr. Harless is also affiliated with Charleston Area Medical Center General Hospital. The medical group on file is Parkview Physicians Group, Midwest Community Health Associates. Dmand AI also links Dr. Harless to 2 more hospitals, 4 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Harless practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Harless' primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Harless' licenses on file in 4 states: West Virginia, Alabama, Connecticut and Maine.

CMS data shows 148 Medicare services from Dr. Harless across 2 procedure codes in 2024, all of them office visits, for 111 Medicare patients. Medicare paid $13,744 for them.

CMS counts 111 Medicare patients who saw Dr. Harless in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Harless' median patient age at 71, with 47% women.

In 2024, Dr. Harless wrote 355 Medicare Part D claims for 109 patients. 85% of them were for generic drugs. CMS names the drug for 117 of them, across 7 drugs with 11 or more claims each, at $182,714 in total drug cost. In 2023, CMS named 139 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Harless for performance year 2024, reported through an alternative payment model (APM).

Dmand AI links 10 papers to Dr. Harless, published from 2017 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Antineoplastic Agents, Apoptosis and Aspirin. Dr. Harless has published most often in Cancers (Basel).

CMS Open Payments shows 18 general payments to Dr. Harless from 13 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 55% of the total. Janssen Pharmaceuticals, Inc paid the most, $113.